Abstract
Background: A hallmark of glioblastoma is represented by their ability to widely disperse throughout the brain parenchyma. The importance of developing new anti-migratory targets is critical to reduce recurrence and improve therapeutic efficacy. Methods: Polydimethylsiloxane substrates, either mechanically uniform or presenting durotactic cues, were fabricated to assess GBM cell morphological and dynamical response with and without pharmacological inhibition of NNMII contractility, of its upstream regulator ROCK and actin polymerization. Results: Glioma cells mechanotactic efficiency varied depending on the rigidity compliance of substrates. Morphologically, glioma cells on highly rigid and soft bulk substrates displayed bigger and elongated aggregates whereas on durotactic substrates the same cells were homogeneously dispersed with a less elongated morphology. The durotactic cues also induced a motility change, cell phenotype dependent, and with cells being more invasive on stiffer substrates. Pharmacological inhibition of myosin or ROCK revealed a rigidity-insensitivity, unlike inhibition of microfilament contraction and polymerization of F-actin, suggesting that alternative signalling is used to respond to durotactic cues. Conclusions: The presence of a distinct mechanical cue is an important factor in cell migration. Together, our results provide support for a durotactic role of glioma cells that acts through actomyosin contractility to regulate the aggressive properties of GBM cells.
Keywords: glioblastoma, cell movement, cellular microenvironment, mechanotaxis
1. Introduction
Glioblastoma (GBM) currently represents the most malignant and incurable form of brain tumours. A hallmark of GBM is its highly diffusive invasiveness of tumour cells into the surrounding brain which hinders efficacy of all existing treatments [1]. Glioma cells rarely metastasize to other tissues. However, more than often, single infiltrating cells are found throughout the brain parenchyma, dispersing rapidly along white matter tracts and blood vessel walls [2,3,4,5,6]. This infiltration precludes surgical removal and contributes to recurrence. Respect to their behaviour in the parenchyma, on blood vessel walls, glioma cells act and display different morphologies [7,8,9,10,11,12,13,14,15]. In the parenchyma, a multipolar morphology is usually observed [10,16,17], whereas, in blood vessels, glioma cells show a unipolar elongation. Moreover, glioma cells have shown to shift from a slow, random migration mode (exhibiting lower Rac1 and CDC42 activities), when crossing the parenchyma, to a fast migration course (exhibiting higher RhoA activity) on the linear blood vessels [15,18].
Differences in glioma behaviour respect to the parenchyma and the blood vessels are also related to variations in stiffness [19,20,21,22,23,24,25,26]. Mechanical cues within the extracellular matrix (ECM) environment play a major role in prompting and guiding GBM cells´ invasion. This process often is referred to as “durotaxis” or “mechanotaxis” [27,28,29]. Pilot work showed that effects of stiffness was cell type dependent, demonstrating that GBM cell migration of continuous glioma cell lines increased on more rigid substrates with actin stress fibre formation and focal adhesion maturation. Whereas primary patient-derived GBM lines showed a range of rigidity sensing phenotypes with some lines migrating faster on stiffer substrates, and others rigidity-independent [30,31,32]. Inconsistencies of cell responses to substrate stiffness reported in literature may also stem from the interference of other stimuli, such as topography and chemistry of the surface. Furthermore, the analysis of cells response to mechanical signals has been mainly conducted on mechanically uniform substrates, without the presence of mechanical cues which are, instead, experienced by glioma cells while dispersing within the brain. For this reason, studying cell migration in response to a mechanical cue would be important for understanding glioblastoma biology and glioma invasion during tumorigenesis, thereby providing an important tool to target more effectively the different stages of cancer progression.
The mechanical cues of the microenvironment have shown to affect focal adhesions and actomyosin cytoskeletal arrangements through non-muscle myosin II (NMII) contraction and Rho-kinase [33,34,35]. Many glioma cell types grown on soft substrates exhibited reduced spreading, proliferation, presence of stress fibers, and focal adhesions respect to more rigid substrates [23]. An increase of stiffness involves an increased presence of integrin-associated structural and signalling proteins at the site of adhesion, as well as focal adhesion kinase (FAK), which in turn stimulates the Rho/ROCK (Rho kinase) pathway. Activation of ROCK promotes force generation and regulates myosin light chain (MLC) phosphorylation, NMII engagement with actin and contraction, leading to various cell processes, such as motility and adhesion [36]. Substrate stiffness affects also integrin clustering as well as focal adhesion assembly and turnover [37,38,39,40]. Actin filaments, besides, are implicated in the process of transducing signals by connecting to focal adhesion molecules such as integrins, vinculin and talin [41,42]. Studies suggest that a lack of actomyosin-based contractility reduces cytoskeletal tension in the spreading of cells on softer matrices [43,44]. Yet, it has also been shown that inhibition of non-muscle myosin II or ROCK in gliomas grown on soft substrates rescued their motility and adhesion to levels on compliant rigid substrates [23]. This underlies the fact that the understanding of tensional control of growth, adhesion and motility, gathered mostly from studies on rigid substrates, is incomplete.
In the present study we compare the rigidity dependent migration behaviour of U251 and GL15 GBM cell lines on uniform and durotactic polydimethylsiloxane (PDMS) substrates. In particular, these durotactic substrates present a double structure with underlying topographical features, which result in controlled mechanical cues projected on the overlying uniform membrane. Using long-term imaging, we found that the geometrical confinement induced by the mechanical cues plays an important and specific role in glioma migration and morphology, suggesting that the invasion of GBM can be conditioned also by the presence of a geometrical mechanical restriction.
We also examined the effect of the pharmacological inhibition of myosin activity with blebbistatin, Rho kinase with ROCK Y27632, or actin dynamics with cytochalasin D (Cyto. D) on cell response to different substrate rigidities. Results showed that inhibition of NMMII or ROCK corroborated a cell insensitivity to the mechanical environment, whereas inhibition of actin polymerization increased the mechanosensitivity.
This study provides the first evidence for GBM cell durotaxis on a definite mechanical cue and further defines stiffness gradient design parameters to support directed migration and cell elongation, questioning previous results reported on flat uniform rigid samples.
These findings can be important for the development of new therapeutic strategies which target invasiveness of GBM cells.
2. Results
2.1. Substrate Characterization
To test the effect of matrix stiffness on cell migration and morphology, U251 and GL15 glioma cells were cultured on polydimethylsiloxane (PDMS) substrates. Bulk and micropatterned lines 50 × 150 µm and 15 × 15 µm were fabricated as previously described, and shown in Figure 1 [27,45].
Bulk uniform substrates were obtained by simply pouring a base to curing ratio of opportune rigidity (3:1 for very stiff and 50:1 with heptane for very soft) in petri dishes, as schematically shown in Supplementary Materials, Figure S1. We referred to these from here onwards as the bulk stiff and bulk soft substrates, respectively.
Durotactic substrates with a stiffness cue were obtained by bonding a thin PDMS membrane, of base to curing ratio of 50:1 of about 10 µm, to the micropatterned substrate so as to display a topographically and chemically uniform substrate, while delivering a mechanical gradient dictated by the micropattern underlying the membrane. Generally speaking, a stiffer substrate was achieved with the PDMS membrane on the micropatterned lines (150 µm) while a softer substrate was obtained with the only thin membrane (without the underlying pattern, i.e., 50 µm) as schematically reported in Supplementary Materials, Figure S1. We referred to them from here onwards as the stiff and soft substrates, respectively.
Quantification of the elasticity of these substrates were characterized in terms of nanoindentation and the longitudinal modulus. The longitudinal modulus of the thin membrane, measured with Brillouin microscopy, corroborated the presence of a uniform substrate without topographical variation which was estimated to be M′ = 0.988 ± 0.015 GPa, Figure 1d, lower than the underlying PDMS bulk substrate (M′ = 1.070 ± 0.016 GPa), Figure 1e. This confirmed that the PDMS lines can deliver a rigidity cue. Indentation arrays performed using a rigid spherical indenter AFM tip showed a Young modulus of the bulk stiff and bulk soft substrates respectively of E = 12.6 MPa and E = 3.2 MPa, and E = 9 MPa on the stiff substrate and 5 MPa on the soft, Figure 1f.
2.2. Glioblastoma Cell Morphology was Sensitive to Different Discrete Mechanical Stiffness in Particular to the Mechanically Uniform Durotactic Substrates
To delineate the effect of substrate stiffness on cell morphology we cultured both cell lines on the different mechanically uniform and micropatterned durotactic PDMS substrates. Both cell lines formed colonies and spherical aggregates when plated on the uniform bulk stiff and soft PDMS substrates but these were not observed on the durotactic substrates where cells were mostly consistently distributed. A higher number of smaller clusters in volume were observed on bulk soft substrates from which cells dispersed widely and more homogenously respect to the bulk stiff substrates where clusters were less and more voluminously grouped (Figure 2).
These observations suggest that a lower stiffness of the ECM may interact more strongly with the cytoskeleton of cells from glioblastomas than that of higher stiffness. Quantitatively, cells cultured on the uniform bulk substrates showed a distinct morphologic phenotype as compared to those cultured on the durotactic substrates. In particular, on the different mechanically uniform substrates, we observed significant differences within the cell spread area, with a higher surface area on the bulk soft substrates for both cell lines (Figure 2 and Supplementary Materials, Figure S2). Whereas, the area on the mechanically gradient substrates was strongly reduced with the stiffness and geometrical mechanical confinement, although no significant differences were observed across the stiff and soft micropatterned substrates.
Shape descriptors such as the Feret diameter, the circularity ratio and axis ratio (A.R.) were also quantified. Large Feret diameters correspond to longer extensions from the cells, i.e., protrusions. A.R. basically represents a measure of how “elongated” is the cell’s shape. On the mechanically uniform bulk, U251 cells showed a lower A.R. on the bulk soft (Figure 2g) as opposed to the GL15 (Supplementary Materials, Figure S2g). This result reveals that GL15 were more elongated and produced more protrusions, whereas the U251 were larger and rounder. Cells of both lines were unexpectedly less elongated on the micropatterned durotactic substrates, (Figure 2f, Supplementary Materials, Figure S2f).
The circularity represents how much the cell’s shape differs from a circle. A lower number for the circularity indicates a more stretched shape and/or longer/larger number of protrusions. In detail, this data reinforced the evidence that U251 on the bulk soft substrates were significantly rounder on mechanically uniform substrates, (Figure 2h). On the other hand, GL15 were more rounded on the stiffer substrates respect to the gradient durotactic substrates (Supplementary Materials, Figure S2h).
We next explored the F-actin cortical cytoskeleton morphology and focal adhesions with phalloidin and anti-vinculin, respectively. Fluorescent images of U251 and GL15 on bulk and durotactic flat and micropatterned substrates are shown in Figure 3 and Supplementary Materials, Figure S3, respectively.
Both cell lines, on bulk soft substrates, displayed thin and short protrusions, with red fluorescence from phalloidin, representing F-actin fibres (Figure 3h, Supplementary Materials, Figure S3h) and a located clustering of adhesion components on the periphery of the cell (more evident for the U251 than the GL15). Cells on the bulk stiff substrates instead displayed focal adhesion and F-actin meshworks more delimited at the cell periphery, indicating that the stiffening of the surrounding area induces F-actin organization. Compared with the bulk substrates cells on durotactic substrates lost their rounded morphology and became stellate and protrusive with actin filaments aligned with the underlying pattern and focal adhesion complexes uniformly distributed.
2.3. Cell Speed is Differentially Regulated by Substrate Stiffness
To clarify which substrate was the most efficient to stimulate motility in both glioma cell lines, we investigated the speed dependency on the different substrate by performing time-lapse microscopy. Statistical analysis comparing directionality, total displacement, length and instantaneous speed on the uniform bulk and durotactic substrates showed a difference between cell lines (Figure 4). Both cell lines did not show a preferential directionality on the substrates (Figure 4a; Supplementary Materials, Figure S4a), but migrated further on stiffer substrates respect to the soft (Figure 4b,c, Supplementary Materials, Figure S4b,c). Comparison of instantaneous speed of the tracked cells on the stiff and soft durotactic substrates and on the bulk substrates also confirmed a higher migration rate in response to increasing substrate stiffness in both cell lines (Figure 4d; Supplementary Materials, Figure S4d). This indicated that stiffer substrates supported better migration of both glioma cell lines.
The migration paths of the individual cells on the different substrates was further analysed through the mean squared displacement (MSD), which gives an indication on how far a cell migrates in a given time interval (Figure 4e, Supplementary Materials, Figure S4e). Interestingly, the MSD of the U251 cells on the durotactic substrate was greater than that on the bulk (see Figure 4e), consistent with the dynamic velocity data. On the other hand, the MSD of the GL15 cells monotonically increased with the bulk substrate stiffness respect to the durotactic substrates (Supplementary Materials, Figure S4e). Moreover, the MSD on the durotactic substrates was indistinguishable for stiff and soft durotactic rigidities, showing a rigidity insensitivity of both cell lines. Typically, in a diffusive process, MSD is a linear function of time, whereas a non-linear dependence in time of the MSD is found in anomalous diffusion processes. By plotting as a function of time interval, we obtained in U251 cells and in GL15 cells. These results indicate that (i) GL15 cells movement on all substrates are more or less super-diffusive, and that (ii) U251 cells movement are strongly super diffusive. This suggests that the U251 on the durotactic substrates have more active cellular migrating processes and cells spread more widely after long time periods.
Because both the directionality and the MSD are strongly biased by speed, we computed also the direction autocorrelation, which measures how angles describing the trajectory are aligned with each other. The direction autocorrelation plot confirmed a difference of migration of both cell lines on both bulk and durotactic substrates (see Figure 4f, Supplementary Materials, Figure S4f) [46].
The curve of U251 cells decays slower over time for durotactic substrates rather than on the bulk where they rapidly decreased to zero. This result indicates a higher degree of directionality on bulk substrates for U251 cells as opposing to the GL15 cells, confirming a strong effect of the mechanical geometrical gradient on cell movement.
2.4. Cell Viability is not Influenced by Substrate Stiffness
Cell growth and apoptosis are closely related to cell shape and adhesion, therefore the sensitivities of U251 and GL15 cells to the durotactic substrates were analysed by measuring cell viability with the MTT assay (Supplementary Materials, Figure S5) after 24, 48, 72 h after culture. Results indicated higher ratio of cell viability among both cell lines for cells cultured on durotactic flat substrates respect to bulk substrates. The highest viability decrease (20%) was observed for GL15 cells between the bulk stiff and soft substrates whereas the same was observed for the U251 only after 48 and 72 h. Lower viability decreases for U251 are consistent with their growth.
To quantitate the durotactic induced apoptotic cell death in U251 and GL15 cells, approximately 105 U251 and GL15 cells were double stained with Annexin-V-FITC and propidium iodide (PI) on the durotactic, bulk stiff and bulk soft substrates. FACS analysis identified less apoptic cells on the flat durotactic substrates.
2.5. Inhibition of Myosin and RhoA is Morfologically Affected by the Durotactic Substrate Stiffness but not Dynamically
Collectively, our data suggests that both U251 and GL15 cell migration is influenced by the geometrical constrainments of the mechanical cues of the durotactic substrates. We therefore proceeded to determine whether RhoA/actin/cell rigidity signalling was involved behind the observed durotactic cell migration. In order to identify the cytoskeletal components contributing to cell motility observed in this study, we tested the role of inhibitors targeting the RhoA pathway including ROCK (Y-27632), the cytoskeleton-associated motor proteins components of myosin II (blebbistatin) (Figure 5, Supplementary Materials, Figure S6).
In the presence of blebbistatin at a concentration of 25 µM (an inhibitor of non-muscle myosin II), and of the Rho-associated kinase inhibitor ROCK Y27632 at a concentration of 10 µM, both cell lines assumed a stellate-shape showing a lack of actin fibril organization. Qualitatively, cells treated with blebbistatin showed a reduced area and a less elongated morphology on the stiff and soft lines respect to the flat (Figure 5a, Supplementary Materials, Figure S6a). Similarly, inhibition of ROCK via Y27632 showed a decrease of the spread area but no significant differences between elongation, aspect ratio and circularity across uniform and the micropattern of durotactic substrates were observed (Figure 5b). The opposite was seen for the GL15 cells treated with blebbistatin which showed an increase of the area and elongation particularly on the micropatterned durotactic substrates (Supplementary Materials, Figure S6a). Inhibition of ROCK reduced the area of cells, which, however, were larger and more elongated on the durotactic micropatterned substrates respect to the flat (Supplementary Materials, Figure S6b).
Quantitatively, inhibition of blebbistatin tracks increased U251 speed especially on the soft micropatterned sections of the durotactic substrates (Figure 5c,d) whereas Y27632 reduced glioma cell migration on the flat and stiff micropatterned sections respect to the soft which remained quantitatively the same (Figure 5c,d). On the other hand, we found that blebbistatin reduced migration of GL15 cells on the micropatterned durotactic substrates respect to the flat (Supplementary Materials, Figure S6c,d), as well as inhibition with Y27632.
Comparison of the MSD plots of migration of both cell lines inhibited with blebbistatin, indicated that migration was higher for the flat uniform substrates respect to the micropatterned durotactic ones (Figure 5e, Supplementary Materials, Figure S6e). This implicates that the mechanical cue induced a more confined movement of cells respect to when cultured on flat uniform substrates. Whereas, MSD analysis of ROCK inhibition via Y27632 of both cell lines presented a mean cell speed on the flat substrate, approximately equivalent to the durotactic substrate, suggesting that the ROCK-myosin II pathway was not implicated on the observed durotactic cell migration (Figure 5f, Supplementary Materials, Figure S6f).
2.6. Inhibition of Actin Polymerization Increases Mechanotaxis of Cells
To investigate the involvement of the actin cytoskeleton, both cell lines were treated with Cyto. D, an actin-disrupting agent, at a concentration of 1 µM, Figure 6, Supplementary Materials, Figure S7).
Comparison of wind-rose plots of tracked cells indicated that migration decreased in response to inhibition with Cyto.D (Figure 6a,b; Supplementary Materials, Figure S7a,b). The inhibitor interfered also with the cellular spreading (Figure 6c, Supplementary Materials, Figure S7c) preventing protrusion formation. Imaging with time-lapse microscopy, showed suppressed actin assembly of U251 and GL15 cells with impaired motility and lack of movement, but the effect of Cyto. D on the sensitivity to the mechanical cue of the substrate appeared to be cell specific. The average speed and the overall migration were dramatically reduced in both cell lines upon Cyto. D treatment (U251 median speed was reduced of 43.1% on the flat respect to its control, and about 42 ± 3% on the stiff and soft lines, Figure 6e; GL15 median speed reduced of 35.7% in control, and 29.2 ± 0.4% on the stiff and soft lines Supplementary Materials, Figure S7e), indicating that cells are dependent on actin filaments. MSD vs. time curves showed a confined motility for both cell lines but also that substrate stiffness effected cell motion and this effect is stronger for stiffer substrates with U251 faster on stiff lines (Figure 6f) as opposed to GL15 cells (Supplementary Materials, Figure S7f).
Taken together this evidence points to a role for a binding protein or a receptor-mediated mechanism in connection, to the substrate stiffness, indicating that actin was involved, although U251 cells seemed to be more sensitive to actin depolymerization than GL15 cells.
2.7. Effects of Inhibition on F- actin and Focal Adhesions Organization on GBM Cells
Cell adhesion response to the different substrates could result from the different expression of cellular adhesion molecules [43,47,48]. Activation of Src kinase and FAK have been shown to promote cell migration. FAK is activated by autophosphorylation of Tyr397, a site recognized by Src kinase. Src regulates cellular migration through substrates. For example, Src phosphorylates and modulates focal adhesion assembly and migration [49]. Our results on Fak and p-FAK Tyr397 agree with previous reports on substrates with varying degrees of stiffness showing that phosphorylation levels of U251 cells increased with increasing substrate rigidity. To establish that blebbistatin, Y27632 and Cyto. D were in fact inhibiting Rho kinase and decreasing FAK phosphorylation, we quantified the changes in FAK and FAK phosphorylation.
Western blot analysis confirmed the expression of FAK and phosphorylated FAK on bulk stiff, bulk soft and flat durotactic substrates indicated by the bands (see Figure 7, Supplementary Materials, Figure S8) corresponding to these kinases. By inhibition of actomyosin contraction with blebbistatin, FAK and phosphorylation levels were slightly reduced on the bulk stiff and bulk soft substrates. Remarkably with Cyto. D treatment these levels increased predominantly on the bulk soft substrates. On the contrary for the GL15, inhibition of blebbistatin and ROCK increased FAK phosphorylation on the stiff bulk substrates whereas these were lower for Cyto. D. These results confirm that FAK is a candidate for the adhesion signalling pathway, which exhibits a site-specific response to substrate stiffness. Involvement of Src signaling in the control of cell migration also confirmed FAK expression.
Confocal images of U251 and GL15 cells pre-treated with blebbistatin, Y27632 and Cyto. D cultured either on flat compliant substrates or the durotactic substrate (stiff and soft lines) revealed disruption of stress fibres and clear decrease of the bundling of actin stress fibres and the relative size of the focal adhesions in focal adhesion after treatment (Figure 7e–j, Supplementary Materials, Figure S8e–j). Cells of both lines treated with Cyto. D exhibited disrupted actin fibril organization.
3. Discussion
Cell behaviour is strongly influenced by the biophysical cues of the environment. Previous studies established that cells behave differently on substrates of distinctive uniform rigidities [23,31,44,50]. Our work extends this current body of knowledge, providing evidence that the presence of mechanical cues of the underlying surface can differentially modulate glioma cell behavior respect to uniform substrates. Specifically, the presence of a mechanical cue regulated, in a cell line specific manner, the morphology, the anchorage and the motility of glioma cells. This work is the first study to our knowledge which shows discrimination of these parameters based on the presence of a mechanical cue.
In particular, results showed that glioma cells adhered differently to the various substrates. Remarkably, we noticed that both U251 and GL15 cells formed initially aggregates only on stiff and soft bulk substrates (Figure 2). Of note, it appeared that on stiff bulk substrates there was a reduced amount of aggregates, with promotion of cell–cell cohesion at the advancing cell front, where cells were tightly adherent to one another (Figure 3). Whereas on the bulk soft substrates, a higher number of aggregates was observed with cells dispersing from the aggregates as single cells from the advancing edge, with shorter protrusions spreading from the cells (Figure 3). This suggests that cells may actively reorganize their actin cytoskeleton to probe and invade the matrix. Conversely, on the durotactic substrates cells were more uniformly spread, deprived of aggregates with a more spindle-like morphology.
Previous reported studies suggest that the different rigidity-dependent responses might reflect sub-class specific behaviours of cell lineages [31,32]. For example, Grundy and coworkers (2016), reported rigidity-dependent responses between patient derived cell lines. Some cultures spread and generated actin stress fibres on more rigid substrates, while others showed ridigity-insensitive phenotypes [32]. Consistently, we observed cells more well spread on the durotactic substrates respect to uniform substrates. However, the rigidity and geometrical mechanical confinement of the substrate induced a smaller size and a more elongated shape of cells.
The durotactic cues also strongly influenced cell migration response respect to the bulk uniform substrates. It has been reported that substrate rigidity can induce different migratory responses in different tumour cells [32]. In our study, the two investigated cell lines showed significant similarities, as both exhibited an increased speed of migration on the stiff substrates. However, cells also exhibited distinct behaviours, with U251 showing an increase of cell speed on the durotactic cues respect to the bulk while the GL15’s displayed an opposite behaviour (Figure 4d, Supplementary Materials, Figure S4d). Cell migration may occur through different modes of migration which can be mesenchymal or amoeboid depending whether cells generate paths in the matrix via secretion of matrix metalloproteinases (MMPs), or employ morphological alterations to move through pores in the matrix, respectively [51]. The aspect ratio can be used to distinguish between mesenchymal and amoeboid phenotypes [52]. Cells with ratio of the major to minor axes higher than 1.5 are ranked as mesenchymal, whereas a value below 1.5 indicates an amoeboid phenotype. Based on the value of the aspect ratio, both U251and GL15 showed a mesenchymal phenotype (Figure 2g; Supplementary Materials, Figure S2g), confirming a stiffness dependent motility.
Several studies have described contradicting roles of the Rho GTPases and myosin II in GBM tumor progression, due to the different experimental systems reported [23]. For example, responses in glioma invasion with suppression of myosin II and/or activation of Rac and RhoA are significantly variable depending on physical microenvironments. Indeed, continuous culture models of GBM lines have shown to necessitate of myosin II and its upstream regulators to sense and respond to ECM rigidity [23,44,53], while primary cell lines were reported to be rigidity-insensitive [31,32]. Interestingly, treatment with either Y27632 or blebbistatin supported the notion of cell lines insensitivity to a rigidity gradient on our substrates. This would suggest that these treatments do not exert a significant selective effect.
An increase of the RhoA activity in glioblastoma cells has been associated with decreased motility and invasiveness and formation of stress fibres and focal adhesions [54,55]. Moreover, we observed in all substrates a reduced expression of vinculin (Figure 7, Supplementary Materials, Figure S8) in the presence of blebbistatin or Y27632. This was consistent with several studies, showing that inhibition of myosin II contractility or Rho kinases affects the process of integration of key mechanosensing proteins, such as vinculin, into focal adhesions [35,56].
Earlier evidence reported that actin cytoskeleton perturbation with cytochalasin D reduced cell movement, regardless substrate stiffness [23,57]. We, too, observed that inhibition of actin polymerization interfered with cell motility. Moreover, we observed that cytochalasin D treatment restored sensitivity to the ECM stiffness. However, U251 were faster on stiff substrates while GL15 were slower.
Also, we did not observe vinculin positive focal adhesions, while cells reverted to a rounder shape. This suggested that cytochalasin D led to adhesions failure rather than maturation. Disruption of actin filaments has showed to induce proMMP-2 activation and loss of MMP-9 expression [58,59,60]. Our preliminary efforts to identify the pathways that control the stiffness dependency did not point out obvious candidates, indicating that more work is needed to elucidate the underlying molecular network controlling this cellular response.
In summary, we have documented an intriguing role for durotactic cues respect to uniform substrates in regulating the balance between adhesion and motility of different cell lines. Generally, studies in literature of migration on 2D surfaces do not adequately represent the mechanical constraints present within the brain. Using PDMS elastomers, which allowed to modulate the rigidity of the substrate, we demonstrated that the presence mechanical cues can induce different changes in glioma cells. This kind of substrate can provide additional information respect to normally used rigid uniform surfaces. Indeed, using a durotactic substrate, we show that interfering with actin-polymerization dynamics, effectively blocked cell migration. In addition, we also provide evidence that this treatment highlights a cell dependent sensitivity to the substrate rigidity.
The results reported in this study may facilitate the development of optimal in vitro platforms to mimic in vivo conditions to study cancer cell migration and to uncover therapeutic strategies against tumour cell motility and invasion.
4. Materials and Methods
4.1. Materials
All tissue culture media were purchased from Life Technologies (Carlsbad, NM, USA). All chemical reagents were obtained from Sigma-Aldrich (Steinheim, Germany), unless otherwise stated. AnnexinV-PI kit was acquired from Abcam (Cambridge, UK), Coomassie brilliant blue staining from BioRad (Hercules, CA, USA).
4.2. Cell Cultures
Glioblastoma-derived human cell lines U251and GL15 (kindly provided by Dr. Emilia Castigli, Perugia University) were cultured in DMEM (Invitrogen, San Diego, CA, USA) supplemented with 10% heat-inactivated FBS (Invitrogen), 100 IU/mL penicillin G, 100 μg/mL streptomycin, 2 mM glutamine, and 1 mM sodium pyruvate. Cells were grown at 37 °C in a 5% CO2 humidified atmosphere.
4.3. Preparation of PDMS Uniform and Gradient Durotactic Substrates
To obtain chemically and topographically uniform substrates of varying stiffness gradients, double sandwich polydimethylsiloxane substrates were used. Substrates were made according to previous reports [27]. Substrates were washed and sterilized with 70% ethanol. To promote cell adhesion, PDMS surfaces were treated with 100 μg/mL poly-l-lysine 1 mg/mL under UV light for ~15 min.
4.4. Characterization of Substrates
4.4.1. Brillouin Measurements
A custom-built Brillouin microscope was used to measure the spatial distribution of the membrane stiffness and underlying pattern. Brillouin microscopy with a single-longitudinal mode laser beam (Verdi V12, Coherent, Santa Clara, CA, USA) was applied and focused on the membrane using a high numerical aperture (NA = 1.4) objective lens. The light scattered inelastically by the sample was collected in confocal mode using a single mode optical fiber (460P, Thorlabs, Munich, Germany) and analysed through an apodized single-stage VIPA spectrometer. [61] From the measured Brillouin frequency shift (νB) of the Brillouin peaks, the real part of the longitudinal modulus (M′) indicative of the material stiffness was estimated using the relationship M′ = ρ(λνB/2n)2, where ρ = 965 kg/m3 is the material density, n = 1.4 the refractive index and λ = 532 nm the laser wavelength.
4.4.2. AFM Measurements
Mechanical characterization was performed at nano- and micro- scale by atomic force microscopy (AFM). Measurements were performed in air by employing a commercial digital microscope Multimode 8 (Bruker, Milan, Italy) using two different probes: a silicon nitride SPM with 8 nm apical radius (RFESPA, Bruker) and 6.6 um radius colloidal particle mounted on silicon nitride cantilever (CP-PNPL-SiO-C, sQUBE). Preliminary topographic maps were performed acquiring tapping-mode AFM images with RFESPA probes. The tip was indented into the PDMS substrate at a rate of 2.5 μm/s to produce a force-distance curve. Experiments were conducted across multiple samples prepared independently, with 20 measurements within a 100 × 100 μm2 area, which was averaged to give each independent value to be used in data representation and statistical analysis. Young’s modulus, or stiffness of the substrate was calculated from the force curves according to Hertz model which describes the elastic deformation (E).
4.5. Cell Morphological Analysis
Cells of related durotactic and inhibition experiments were fixed for 20 min with 4% (w/v) paraformaldehyde in phosphate buffer saline (PBS), and stained with 0.1% Coomassie Brilliant Blue in 50% methanol, 10% acetic acid for 1 hr and destained with 10% methanol and 7.5% acetic acid. Substrates were subsequently visualized using an inverted microscope (Olympus) equipped with a QImaging (Crisel, Rome, Italy) camera with 10× objectives (Plan N, NA = 0.25, Ph1) or 20× (LUCPlan FLN, NA = 0.45, Ph2). Brightfield images of 10 random microscopic fields were acquired per sample. Cell morphology was characterized using the particle measurement feature within ImageJ (www.nih.gov) to obtain spread area, circularity, aspect ratio (A.R.) and Feret’s diameter of single cells. Circularity of cells were obtained using the formula: Circularity = 4π (area/perimeter2). A circularity value of 1.0 indicates a perfect circle, and values near zero indicate a more elongated morphology of cells. Feret’s diameter is a measure of cell length, and represents the highest distance between any two points along the cell perimeter. The aspect ratio (A.R) is defined as the ratio between the major axis (M) and the minor axis (m) of the cell’s fitted ellipse, calculated by the ImageJ software.
4.6. Time-lapse Microscopy and Quantitative Analysis of Cell Migration
Cells were seeded on the bulk and durotactic PDMS substrates 24 h before imaging. Time-lapse imaging was conducted on an Olympus IX73 inverted microscope, equipped with a QImaging OptiMOS sCMOS camera (QImaging, Surrey, BC, Canada) and in a stage-mounted incubator with CO2 and temperature control (H201; Okolab, Pozzuoli, Italy). Bright field images were acquired every 2 min using a 10× (Plan N, NA = 0.25, Ph1) or 20× (LUCPlan FLN, NA = 0.45, Ph2) objective. Acquisitions were typically acquired over a period varying from 8 to 10 h. Cell bodies were tracked using the manual tracking plugin (mtrackj) for Fiji software over 8 h of migration as previously described [62]. Individual cell tracks from time-lapse microscopy were recorded over time, and set to a common origin for spatial comparison. Results from a minimum of three separate experiments with up to 30–40 individual tracked cells were pooled for data analysis. The trajectories and parameters such as track lengths, displacement (Euclidean distance at each time point), cell instantaneous speed, directionality (track length [the last position minus the initial position] divided by the total displacement of the cell), mean square displacement (MSD) and direction autocorrelation function were plotted using Origin software. The MSD, and direction autocorrelation were calculated using DiPer software. [46] MSD was computed for the tracked cells within each experimental condition and calculated as follows:
< MSD(τ)) > = < (xi(t + τ)−xi(t))2 + (yi(t + τ)−yi(t))2 >, |
where xi and yi denote position of the ith cell in an experimental timelapse frame (x, y), and τ represents the time lag interval. The slope of the linear portion of the MSD curve was fitted in order to characterise the dynamic motion for each of the cells by the following equation [63]:
< MSD(t) > ∝ τ α |
which allowed the power exponent α of the MSD curves to be calculated. If α < 1, a sub-diffusive population is observed, whereas if 1 < α < 2 a super-diffusive is denoted [46]. A one-way Anova test for the mean was used to assess the difference between the mean cellular values across experimental conditions.
4.7. Cell Viability Assay
In vitro cytotoxicity of different substrates against U251, and GL15 cells (5000 cells/mL) was evaluated via MTT assay for 24, 48 and 72 h of incubation, according to the manufacturer’s instructions (Sigma-Aldrich, Milan, Italy).
The absorbance was spectrophotometrically measured at a wavelength of 570 nm and the background absorbance measured at 690 nm was subtracted. The percentage viability was expressed as the relative growth rate (RGR) by following equation:
(1) |
where Dsample and Dcontrol were the absorbance of the sample and the negative control. Each experiment was repeated three times in triplicate (Student’s t-test, p < 0.05).
4.8. Apoptosis Analysis
Cell apoptosis was analyzed by flow cytometry. Briefly, 105 U251 and GL15 cells were seeded of different substrates for 24 h at 37 °C, 5% CO2. After incubation, U251 and GL15 cells were washed with PBS 1× and staining with Annexin V-FITC/PI according to the manufacturer’s instructions (Abcam). Cell apoptosis and cell cycle distribution were determined by analyzing 10,000 ungated cells using a Flow Cytometer (C6, Accuri, Milan, Italy). All experiments were performed in triplicate (Student’s t-test, p < 0.05).
4.9. Inhibition of Cell Contractility
NMMII inhibitor blebbistatin (Sigma-Aldrich), rho-associated kinase (ROCK) inhibitor Y-27632 (Sigma-Aldrich), and actin polymerization inhibitor cytochalasin D (Sigma-Aldrich) were added to the cell culture media in related timelapse and immunofluorescence experiments after the cells had been allowed to adhere for at least 24 h.
4.10. Western Blotting Analysis
Cell protein extract, from GL15 and U251, were obtained using RIPA lysis buffer containing the proteinase inhibitor cocktail. Samples were centrifuged at 10,000 rpm and the surnatant was collected. 30 μg of proteins were dissolved in sodium dodecyl sulfate (SDS) sample buffer and separated on 10% (w/v) polyacrylamide SDS gels. Separated proteins were transferred electrophoretically onto nitrocellulose membrane (Amersham Hybond ECL Nitrocellulose Membrane-GE, Abcam). The filter was blocked with 5% (w/v) non-fat dried milk in buffered saline. Blots were incubated overnight with specific primary antibodies directed against FAK 1:1000 (ZF002, Invitrogen), p-FAK 1:1000 (700255, Invitrogen), SRC 1:1000 (WH0006714M1, Sigma), β-actin 1:5000 (A1978, Sigma). The immune complexes were detected using peroxidase-conjugated secondary antibodies by chemiluminescence (Clarity™ Western ECL Substrate, BioRad). Densitometric analysis was carried out on the western-blots using the C-DiGit Blot scanner (LI-COR, Cornaredo Milano, Italy), normalizing to β-actin used as an internal control.
4.11. Immunofluorescence
Cells were fixed using 4% paraformaldehyde in PBS for 20 min at room temperature before being permeabilized with 0.2% (v/v) Triton X-100 in PBS for 5 min and blocked with PBS containing 1% BSA. Cells were then labeled with primary antibodies anti-vinculin (mouse) antibody (Sigma) (1:100) and phalloidin-TRITC (Sigma) (1:500) in blocking buffer at 4 °C at 37 °C, and washed in PBS. Fluorescent dye (DYE-Light)-conjugated secondary antibodies against goat IgG were used at a dilution of 1:500 for 1 h at 37 °C in blocking buffer. After washing in PBS the samples were mounted with HOECHST 33258 (Sigma), 1 mg/mL in PBS 1× for 5 min. Cells were viewed on a Confocal microscopy system (Olympus) equipped with a 20× (UPlan FLN, NA 0.50), 40× (UPlanFLN, NA 1.30, oil) and 60× (UPlanSApo, NA 1.35, oil) with a resolution of 1024 × 1024 pixels.
4.12. Statistics
All statistical analysis was performed by using Origin 8 (Arezzo, Italy). Data was reported as mean ± standard error of the mean (S.E.M), a one-way ANOVA with Tukey’s post-hoc analysis was performed to determine differences amongst substrates. Data were considered statistically significant for a * p ≤ 0.05, ** p ≤ 0.01, and *** p ≤ 0.001.
5. Conclusions
In conclusion this study assesses glioma migration in a two-dimensional, topographically uniform surface comparing uniform surfaces with substrates with durotacic cues showing that the latter induces different morphological and dynamical response respect to simple uniform substrates.
To our knowledge, this is the first study to report on the effects of a durotactic cue on glioblastoma cells. The results of our study demonstrate that tuning of durotactic stimuli can profoundly affect cell morphology and motility A better understanding of studies on extracellular matrix and cytoskeleton organization and the associated changes in gliomas will be of crucial importance due to the highly infiltrative nature of these tumours allowing to design treatments in the future.
Supplementary Materials
The following are available online at https://www.mdpi.com/2072-6694/11/5/643/s1, Figure S1: Schematization of the substrates used to culture cells with different mechanical rigidities and cues. Figure S2: GL15 glioma cells’ dynamic properties correlates to the mechanical stiffness of the substrate showing an increased response on the durotactic substrates, Figure S3: Distinctive mechanical stiffness in the diverse microenvironments is dependent on FAK signalling, Figure S4: GL15 glioma cells’ dynamic properties correlates to the mechanical stiffness of the substrate showing a decreased response on the durotactic substrates, Figure S5: Durotactic flat substrates promotes glioma cell proliferation respect to uniform bulk, Figure S6: Durotactic substrates altered the responses of GL15 cells to inhibition of NMMII and ROCK Y27632, responsible for cytoskeleton assembly and cell contractility, Figure S7: Inhibition of actin polymerization with Cyto. D on GL15 on durotactic substrates showed a stiffness-dependent reduced response with a higher sensitivity to soft substrates, Figure S8: FAK, Phosphorylation of FAK Tyr397 and SRC in glioma cells depends on substrate stiffness.
Author Contributions
All authors collected and discussed the material, providing experimental data. I.E.P and S.D. designed and fabricated the substrates and viability of cells. M.T. conducted the western blotting analysis. A.L. and G.A accomplished surface characterization analysis. A.D. and P.R. performed the time-lapse imaging and morphological analysis. S.D.A and D.R. supervised the work and provided experimental advice. I.E.P and B.C. conceived the project, planned and guided the research, and wrote the paper.
Funding
The research leading to these results has received funding from AIRC under MFAG 2015—ID. 16803 project—P.I. Cortese Barbara”. This work was also partially funded by Progetto FISR—C.N.R.: “Tecnopolo di Nanotecnologia e Fotonica per la Medicina di Precisione”—CUP B83B17000010001.
Conflicts of Interest
The authors declare no conflict of interest.
References
- 1.Hou L.C., Veeravagu A., Hsu A.R., Tse V.C. Recurrent glioblastoma multiforme: a review of natural history and management options. Neurosurg. Focus. 2006;20:E5. doi: 10.3171/foc.2006.20.4.2. [DOI] [PubMed] [Google Scholar]
- 2.Beauchesne P. Extra-neural metastases of malignant gliomas: myth or reality? Cancers. 2011;3:461–477. doi: 10.3390/cancers3010461. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Hamilton J.D., Rapp M., Schneiderhan T., Sabel M., Hayman A., Scherer A., Kropil P., Budach W., Gerber P., Kretschmar U., et al. Glioblastoma multiforme metastasis outside the CNS: three case reports and possible mechanisms of escape. J. Clin. Oncol. 2014;32:e80–e84. doi: 10.1200/JCO.2013.48.7546. [DOI] [PubMed] [Google Scholar]
- 4.Nagano N., Sasaki H., Aoyagi M., Hirakawa K. Invasion of experimental rat brain tumor: early morphological changes following microinjection of C6 glioma cells. Acta Neuropathol. 1993;86:117–125. doi: 10.1007/BF00334878. [DOI] [PubMed] [Google Scholar]
- 5.Holash J., Maisonpierre P.C., Compton D., Boland P., Alexander C.R., Zagzag D., Yancopoulos G.D., Wiegand S.J. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science. 1999;284:1994–1998. doi: 10.1126/science.284.5422.1994. [DOI] [PubMed] [Google Scholar]
- 6.Esmaeili M., Stensjøen A.L., Berntsen E.M., Solheim O., Reinertsen I. The Direction of Tumour Growth in Glioblastoma Patients. Sci. Rep. 2018;8:1199. doi: 10.1038/s41598-018-19420-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Zagzag D., Amirnovin R., Greco M.A., Yee H., Holash J., Wiegand S.J., Zabski S., Yancopoulos G.D., Grumet M. Vascular apoptosis and involution in gliomas precede neovascularization: a novel concept for glioma growth and angiogenesis. Lab. Invest. 2000;80:837–849. doi: 10.1038/labinvest.3780088. [DOI] [PubMed] [Google Scholar]
- 8.Grobben B., De Deyn P.P., Slegers H. Rat C6 glioma as experimental model system for the study of glioblastoma growth and invasion. Cell and Tissue Res. 2002;310:257–270. doi: 10.1007/s00441-002-0651-7. [DOI] [PubMed] [Google Scholar]
- 9.Lugassy C., Haroun R.I., Brem H., Tyler B.M., Jones R.V., Fernandez P.M., Patierno S.R., Kleinman H.K., Barnhill R.L. Pericytic-like angiotropism of glioma and melanoma cells. Am. J. Dermatopathol. 2002;24:473–478. doi: 10.1097/00000372-200212000-00003. [DOI] [PubMed] [Google Scholar]
- 10.Farin A., Suzuki S.O., Weiker M., Goldman J.E., Bruce J.N., Canoll P. Transplanted glioma cells migrate and proliferate on host brain vasculature: A dynamic analysis. Glia. 2006;53:799–808. doi: 10.1002/glia.20334. [DOI] [PubMed] [Google Scholar]
- 11.Bellail A.C., Hunter S.B., Brat D.J., Tan C., Van Meir E.G. Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion. Int. J. Biochem. Cell Biol. 2004;36:1046–1069. doi: 10.1016/j.biocel.2004.01.013. [DOI] [PubMed] [Google Scholar]
- 12.Sahm F., Capper D., Jeibmann A., Habel A., Paulus W., Troost D., von Deimling A. Addressing Diffuse Glioma as a Systemic Brain Disease with Single-Cell Analysis. Arch Neurol. 2012;69:523–526. doi: 10.1001/archneurol.2011.2910. [DOI] [PubMed] [Google Scholar]
- 13.Holland E.C. Glioblastoma multiforme: The terminator. PNAS. 2000;97:6242–6244. doi: 10.1073/pnas.97.12.6242. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Giese A., Bjerkvig R., Berens M.E., Westphal M. Cost of migration: Invasion of malignant gliomas and implications for treatment. J. Clin. Oncol. 2003;21:1624–1636. doi: 10.1200/JCO.2003.05.063. [DOI] [PubMed] [Google Scholar]
- 15.Hirata E., Yukinaga H., Kamioka Y., Arakawa Y., Miyamoto S., Okada T., Sahai E., Matsuda M. In vivo fluorescence resonance energy transfer imaging reveals differential activation of Rho-family GTPases in glioblastoma cell invasion. J. Cell Sci. 2012;125:858–868. doi: 10.1242/jcs.089995. [DOI] [PubMed] [Google Scholar]
- 16.Ivkovic S., Beadle C., Noticewala S., Massey S.C., Swanson K.R., Toro L.N., Bresnick A.R., Canoll P., Rosenfeld S.S. Direct inhibition of myosin II effectively blocks glioma invasion in the presence of multiple motogens. Mol. Biol. Cell. 2012;23:533–542. doi: 10.1091/mbc.e11-01-0039. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Beadle C., Assanah M.C., Monzo P., Vallee R., Rosenfeld S.S., Canoll P. The role of myosin II in glioma invasion of the brain. Mol. Biol. Cell. 2008;19:3357–3368. doi: 10.1091/mbc.e08-03-0319. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Winkler F., Kienast Y., Fuhrmann M., Von Baumgarten L., Burgold S., Mitteregger G., Kretzschmar H., Herms J. Imaging glioma cell invasion in vivo reveals mechanisms of dissemination and peritumoral angiogenesis. Glia. 2009;57:1306–1315. doi: 10.1002/glia.20850. [DOI] [PubMed] [Google Scholar]
- 19.Lefranc F., Brotchi J., Kiss R. Possible future issues in the treatment of glioblastomas: Special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis. J. Clin. Oncol. 2005;23:2411–2422. doi: 10.1200/JCO.2005.03.089. [DOI] [PubMed] [Google Scholar]
- 20.Elkin B.S., Azeloglu E.U., Costa K.D., Morrison B., 3rd Mechanical heterogeneity of the rat hippocampus measured by atomic force microscope indentation. J. Neurotrauma. 2007;24:812–822. doi: 10.1089/neu.2006.0169. [DOI] [PubMed] [Google Scholar]
- 21.Unsgaard G., Rygh O.M., Selbekk T., Muller T.B., Kolstad F., Lindseth F., Hernes T.A. Intra-operative 3D ultrasound in neurosurgery. Acta neurochir. 2006;148:235–253; discussion 253. doi: 10.1007/s00701-005-0688-y. [DOI] [PubMed] [Google Scholar]
- 22.Lopez J.I., Kang I., You W.K., McDonald D.M., Weaver V.M. In situ force mapping of mammary gland transformation. Integr. Bio. 2011;3:910–921. doi: 10.1039/c1ib00043h. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Ulrich T.A., de Juan Pardo E.M., Kumar S. The mechanical rigidity of the extracellular matrix regulates the structure, motility, and proliferation of glioma cells. Cancer Res. 2009;69:4167–4174. doi: 10.1158/0008-5472.CAN-08-4859. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Kim S.N., Jeibmann A., Halama K., Witte H.T., Walte M., Matzat T., Schillers H., Faber C., Senner V., Paulus W., et al. ECM stiffness regulates glial migration in Drosophila and mammalian glioma models. Development. 2014;141:3233–3242. doi: 10.1242/dev.106039. [DOI] [PubMed] [Google Scholar]
- 25.Ananthanarayanan B., Kim Y., Kumar S. Elucidating the mechanobiology of malignant brain tumors using a brain matrix-mimetic hyaluronic acid hydrogel platform. Biomaterials. 2011;32:7913–7923. doi: 10.1016/j.biomaterials.2011.07.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Scherer H.J. Structural Development in Gliomas. Am. J. Cancer. 1938;34:18. [Google Scholar]
- 27.Cortese B., Gigli G., Riehle M. Mechanical Gradient Cues for Guided Cell Motility and Control of Cell Behavior on Uniform Substrates. Adv. Funct. Mater. 2009;19:2961–2968. doi: 10.1002/adfm.200900918. [DOI] [Google Scholar]
- 28.Palamà I.E.D.A.S., Cortese B. Mechanical Guidance of Cell Migration. IAPC Publishing; Zagreb, Croatia: 2016. [Google Scholar]
- 29.Palama I.E., Coluccia A.M., Gigli G., Riehle M. Modulation of alignment and differentiation of skeletal myoblasts by biomimetic materials. Integr. Bio. 2012;4:1299–1309. doi: 10.1039/c2ib20133j. [DOI] [PubMed] [Google Scholar]
- 30.Ruiz-Ontanon P., Orgaz J.L., Aldaz B., Elosegui-Artola A., Martino J., Berciano M.T., Montero J.A., Grande L., Nogueira L., Diaz-Moralli S., et al. Cellular plasticity confers migratory and invasive advantages to a population of glioblastoma-initiating cells that infiltrate peritumoral tissue. Stem Cells. 2013;31:1075–1085. doi: 10.1002/stem.1349. [DOI] [PubMed] [Google Scholar]
- 31.Wong S.Y., Ulrich T.A., Deleyrolle L.P., MacKay J.L., Lin J.M., Martuscello R.T., Jundi M.A., Reynolds B.A., Kumar S. Constitutive activation of myosin-dependent contractility sensitizes glioma tumor-initiating cells to mechanical inputs and reduces tissue invasion. Cancer Res. 2015;75:1113–1122. doi: 10.1158/0008-5472.CAN-13-3426. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Grundy T.J., De Leon E., Griffin K.R., Stringer B.W., Day B.W., Fabry B., Cooper-White J., O’Neill G.M. Differential response of patient-derived primary glioblastoma cells to environmental stiffness. Sci. Rep. 2016;6:23353. doi: 10.1038/srep23353. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Vicente-Manzanares M., Ma X., Adelstein R.S., Horwitz A.R. Non-muscle myosin II takes centre stage in cell adhesion and migration. Nat. Rev. Mol. Cell Biol. 2009;10:778–790. doi: 10.1038/nrm2786. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Conti M.A., Adelstein R.S. Nonmuscle myosin II moves in new directions. J. Cell Sci. 2008;121:11–18. doi: 10.1242/jcs.007112. [DOI] [PubMed] [Google Scholar]
- 35.Wolfenson H., Bershadsky A., Henis Y.I., Geiger B. Actomyosin-generated tension controls the molecular kinetics of focal adhesions. J. Cell Sci. 2011;124:1425–1432. doi: 10.1242/jcs.077388. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Olson M.F. Applications for ROCK kinase inhibition. Curr. Opin. Cell Biol. 2008;20:242–248. doi: 10.1016/j.ceb.2008.01.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Burridge K., Chrzanowska-Wodnicka M. Focal adhesions, contractility, and signaling. Annu. Rev. Cell Dev. Biol. 1996;12:463–518. doi: 10.1146/annurev.cellbio.12.1.463. [DOI] [PubMed] [Google Scholar]
- 38.Zaidel-Bar R., Cohen M., Addadi L., Geiger B. Hierarchical assembly of cell-matrix adhesion complexes. Biochem. Soc. Trans. 2004;32:416–420. doi: 10.1042/bst0320416. [DOI] [PubMed] [Google Scholar]
- 39.Janoštiak R., Pataki A.C., Brábek J., Rösel D. Mechanosensors in integrin signaling: The emerging role of p130Cas. Eur. J. Cell Biol. 2014;93:445–454. doi: 10.1016/j.ejcb.2014.07.002. [DOI] [PubMed] [Google Scholar]
- 40.Schwartz M.A. Integrins and extracellular matrix in mechanotransduction. Cold Spring Harb. Perspect Biol. 2010;2:a005066. doi: 10.1101/cshperspect.a005066. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Schlaepfer D.D., Hanks S.K., Hunter T., van der Geer P. Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Nature. 1994;372:786–791. doi: 10.1038/372786a0. [DOI] [PubMed] [Google Scholar]
- 42.Hynes R.O. Integrins: versatility, modulation, and signaling in cell adhesion. Cell. 1992;69:11–25. doi: 10.1016/0092-8674(92)90115-S. [DOI] [PubMed] [Google Scholar]
- 43.Georges P.C., Janmey P.A. Cell type-specific response to growth on soft materials. J. Appl. Physiol. (1985) 2005;98:1547–1553. doi: 10.1152/japplphysiol.01121.2004. [DOI] [PubMed] [Google Scholar]
- 44.Tilghman R.W., Cowan C.R., Mih J.D., Koryakina Y., Gioeli D., Slack-Davis J.K., Blackman B.R., Tschumperlin D.J., Parsons J.T. Matrix rigidity regulates cancer cell growth and cellular phenotype. PLoS ONE. 2010;5:e12905. doi: 10.1371/journal.pone.0012905. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Palamà I.E., D’Amone S., Coluccia A.M., Biasiucci M., Gigli G. Cell self-patterning on uniform PDMS-surfaces with controlled mechanical cues. Integr. Biol. (Camb.) 2012;4:228–236. doi: 10.1039/C2IB00116K. [DOI] [PubMed] [Google Scholar]
- 46.Gorelik R., Gautreau A. Quantitative and unbiased analysis of directional persistence in cell migration. Nat. Protoc. 2014;9:1931–1943. doi: 10.1038/nprot.2014.131. [DOI] [PubMed] [Google Scholar]
- 47.Howe A., Aplin A.E., Alahari S.K., Juliano R.L. Integrin signaling and cell growth control. Curr. Opin. Cell Biol. 1998;10:220–231. doi: 10.1016/S0955-0674(98)80144-0. [DOI] [PubMed] [Google Scholar]
- 48.LeDuc P.P., LeDuc P.R., Bellin R.R., Bellin R.M. Nanoscale intracellular organization and functional architecture mediating cellular behavior. Ann. Biomed. Eng. 2006;34:102–113. doi: 10.1007/s10439-005-9008-1. [DOI] [PubMed] [Google Scholar]
- 49.Kolch W. Coordinating ERK/MAPK signalling through scaffolds and inhibitors. Nat. Rev. Mol. Cell Biol. 2005;6:827–837. doi: 10.1038/nrm1743. [DOI] [PubMed] [Google Scholar]
- 50.Pogoda K., Bucki R., Byfield F.J., Cruz K., Lee T., Marcinkiewicz C., Janmey P.A. Soft Substrates Containing Hyaluronan Mimic the Effects of Increased Stiffness on Morphology, Motility, and Proliferation of Glioma Cells. Biomacromolecules. 2017;18:3040–3051. doi: 10.1021/acs.biomac.7b00324. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Pathak A., Kumar S. Independent regulation of tumor cell migration by matrix stiffness and confinement. PNAS. 2012;109:10334–10339. doi: 10.1073/pnas.1118073109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Torka R., Thuma F., Herzog V., Kirfel G. ROCK signaling mediates the adoption of different modes of migration and invasion in human mammary epithelial tumor cells. Exp. Cell Res. 2006;312:3857–3871. doi: 10.1016/j.yexcr.2006.08.025. [DOI] [PubMed] [Google Scholar]
- 53.Sen S., Ng W.P., Kumar S. Contractility dominates adhesive ligand density in regulating cellular de-adhesion and retraction kinetics. Ann. Biomed. Eng. 2011;39:1163–1173. doi: 10.1007/s10439-010-0195-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Malchinkhuu E., Sato K., Maehama T., Mogi C., Tomura H., Ishiuchi S., Yoshimoto Y., Kurose H., Okajima F. S1P(2) receptors mediate inhibition of glioma cell migration through Rho signaling pathways independent of PTEN. Biochem. Biophys. Res. Commun. 2008;366:963–968. doi: 10.1016/j.bbrc.2007.12.054. [DOI] [PubMed] [Google Scholar]
- 55.Khalil B.D., Hanna S., Saykali B.A., El-Sitt S., Nasrallah A., Marston D., El-Sabban M., Hahn K.M., Symons M., El-Sibai M. The regulation of RhoA at focal adhesions by StarD13 is important for astrocytoma cell motility. Exp. Cell Res. 2014;321:109–122. doi: 10.1016/j.yexcr.2013.11.023. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Plotnikov S.V., Pasapera A.M., Sabass B., Waterman C.M. Force fluctuations within focal adhesions mediate ECM-rigidity sensing to guide directed cell migration. Cell. 2012;151:1513–1527. doi: 10.1016/j.cell.2012.11.034. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Kiss A., Horvath P., Rothballer A., Kutay U., Csucs G. Nuclear motility in glioma cells reveals a cell-line dependent role of various cytoskeletal components. PLoS ONE. 2014;9:e93431. doi: 10.1371/journal.pone.0093431. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Chintala S.K., Sawaya R., Aggarwal B.B., Majumder S., Giri D.K., Kyritsis A.P., Gokaslan Z.L., Rao J.S. Induction of matrix metalloproteinase-9 requires a polymerized actin cytoskeleton in human malignant glioma cells. J. Biol. Chem. 1998;273:13545–13551. doi: 10.1074/jbc.273.22.13545. [DOI] [PubMed] [Google Scholar]
- 59.Mierke C.T., Rösel D., Fabry B., Brábek J. Contractile forces in tumor cell migration. Eur. J. Cell Biol. 2008;87:669–676. doi: 10.1016/j.ejcb.2008.01.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Gingras D., Page M., Annabi B., Beliveau R. Rapid activation of matrix metalloproteinase-2 by glioma cells occurs through a posttranslational MT1-MMP-dependent mechanism. Biochim. Biophys. Acta. 2000;1497:341–350. doi: 10.1016/S0167-4889(00)00071-9. [DOI] [PubMed] [Google Scholar]
- 61.Antonacci G., Braakman S. Biomechanics of subcellular structures by non-invasive Brillouin microscopy. Sci. Rep. 2016;6:37217. doi: 10.1038/srep37217. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Basilico B., Cortese B., Ratano P., Di Angelantonio S., Ragozzino D. Time-lapse Whole-field Fluorescence Imaging of Microglia Processes Motility in Acute Mouse Hippocampal Slices and Analysis. Bio-protocol. 2019;9:e3220. doi: 10.21769/BioProtoc.3220. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Stokes C.L., Lauffenburger D.A., Williams S.K. Migration of individual microvessel endothelial cells: stochastic model and parameter measurement. J. Cell Sci. 1991;99:419–430. doi: 10.1242/jcs.99.2.419. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.